Literature DB >> 8386195

Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression.

B C Marshall1, A Santana, Q P Xu, M J Petersen, E J Campbell, J R Hoidal, H G Welgus.   

Abstract

Mesothelial cells play a critical role in the remodeling process that follows serosal injury. Although mesothelial cells are known to synthesize a variety of extracellular matrix components including types I, III, and IV collagens, their potential to participate in matrix degradation has not been explored. We now report that human pleural and peritoneal mesothelial cells express interstitial collagenase, 72- and 92-kD gelatinases (type IV collagenases), and the counterregulatory tissue inhibitor of metalloproteinases (TIMP). Our initial characterization of the mesothelial cell metalloenzymes and TIMP has revealed: (a) they are likely identical to corresponding molecules secreted by other human cells; (b) they are secreted rather than stored in an intracellular pool; (c) a primary site of regulation occurs at a pretranslational level; (d) phorbol myristate acetate, via activation of protein kinase C, upregulates expression of collagenase, 92-kD gelatinase, and TIMP, but has no effect on expression of 72-kD gelatinase; and (e) lipopolysaccharide fails to upregulate the biosynthesis of either metalloproteinases or TIMP. Of particular interest is the observation that the state of cellular differentiation has a striking influence on the expression of metalloenzymes and TIMP, such that epitheloid cells display a more matrix-degradative phenotype (increased 92-kD gelatinase and decreased TIMP) than their fibroblastoid counterparts. We speculate that mesothelial cells directly participate in the extracellular matrix turnover that follows serosal injury via elaboration of metalloproteinases and TIMP. Additionally, the reactive cuboidal mesothelium which is characteristic of the early response to serosal injury may manifest a matrix-degenerative phenotype favoring normal repair rather than fibrosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386195      PMCID: PMC288160          DOI: 10.1172/JCI116390

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Calmodulin differentially modulates the interleukin 1-induced biosynthesis of tissue inhibitor of metalloproteinases and matrix metalloproteinases in human uterine cervical fibroblasts.

Authors:  A Ito; T Sato; Y Ojima; L C Chen; H Nagase; Y Mori
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

Review 2.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling.

Authors:  J F Woessner
Journal:  FASEB J       Date:  1991-05       Impact factor: 5.191

3.  Preparation of delipidized serum protein for use in cell culture systems.

Authors:  G H Rothblat; L Y Arbogast; L Ouellette; B V Howard
Journal:  In Vitro       Date:  1976-08

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Pathways of fibrin turnover of human pleural mesothelial cells in vitro.

Authors:  S Idell; C Zwieb; A Kumar; K B Koenig; A R Johnson
Journal:  Am J Respir Cell Mol Biol       Date:  1992-10       Impact factor: 6.914

6.  Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures.

Authors:  G P Stricklin; E A Bauer; J J Jeffrey; A Z Eisen
Journal:  Biochemistry       Date:  1977-04-19       Impact factor: 3.162

7.  Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.

Authors:  P Huhtala; A Tuuttila; L T Chow; J Lohi; J Keski-Oja; K Tryggvason
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

8.  Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.

Authors:  A J Docherty; A Lyons; B J Smith; E M Wright; P E Stephens; T J Harris; G Murphy; J J Reynolds
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

9.  Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha.

Authors:  S H Phan; M Gharaee-Kermani; B McGarry; S L Kunkel; F W Wolber
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

10.  Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/IL-8.

Authors:  R B Goodman; R G Wood; T R Martin; O Hanson-Painton; G T Kinasewitz
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

View more
  15 in total

1.  Phenotypic and functional characteristics of porcine peritoneal mesothelial cells.

Authors:  J Ohan; M A Gilbert; J P Brouland; J P Rougier; G Trugnan; M Wassef; G Leseche; L Drouet
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

2.  Stimulation of mesothelial cell proliferation by exudate macrophages enhances serosal wound healing in a murine model.

Authors:  Steven E Mutsaers; Darrel Whitaker; John M Papadimitriou
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

3.  Ultrastructural acute features of active remodeling after chemical pleurodesis induced by silver nitrate or talc.

Authors:  Eduardo H Genofre; Francisco S Vargas; Leila Antonangelo; Lisete R Teixeira; Marcelo A C Vaz; Evaldo Marchi; Vera Luiza Capelozzi
Journal:  Lung       Date:  2005 May-Jun       Impact factor: 2.584

4.  Growth factor modulation of rat pleural mesothelial cell mitogenesis and collagen synthesis. Effects of epidermal growth factor and platelet-derived factor.

Authors:  M W Owens; S A Milligan
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

5.  Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP-9 test kit.

Authors:  Yuuki Ro; Chieko Hamada; Hiroaki Io; Kayo Hayashi; Ichiro Hirahara; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

6.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages.

Authors:  R W Thompson; D R Holmes; R A Mertens; S Liao; M D Botney; R P Mecham; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme.

Authors:  I Halpert; U I Sires; J D Roby; S Potter-Perigo; T N Wight; S D Shapiro; H G Welgus; S A Wickline; W C Parks
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

8.  Matrix metalloproteinases 2 and 9 increase permeability of sheep pleura in vitro.

Authors:  Eleni Apostolidou; Efrosyni Paraskeva; Konstantinos Gourgoulianis; Paschalis-Adam Molyvdas; Chrissi Hatzoglou
Journal:  BMC Physiol       Date:  2012-03-16

9.  Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells.

Authors:  Roghieh Djafarzadeh; Matthias Sauter; Susan Notohamiprodjo; Elfriede Noessner; Pankaj Goyal; Wolfgang Siess; Markus Wörnle; Andrea Ribeiro; Susanne Himmelein; Thomas Sitter; Peter J Nelson
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

10.  Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro.

Authors:  B Lelongt; G Trugnan; G Murphy; P M Ronco
Journal:  J Cell Biol       Date:  1997-03-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.